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Summary 
The cystic fibrosis transmembrane conductance regu- 
lator (CFTR) functions to regulate both Cl- and Na ÷ 
conductive pathways; however, the cellular mecha- 
nisms whereby CFTR acts as a conductance regulator 
are unknown. CFTR and outwardly rectifying Cl- chan- 
nels (ORCCs) are distinct channels but are linked func- 
tionally via an unknown regulatory mechanism. We 
present results from whole-cell and single-channel 
patch-clamp recordings, short-circuit current record- 
ings, and [7-3=P]ATP release assays of normal, CF, and 
wild-type or mutant CFTR-transfected CF airway cul- 
tured epithelial cells wherein CFTR regulates ORCCs 
by triggering the transport of the potent agonist, ATP, 
out of the cell. Once released, ATP stimulates ORCCs 
through a P=u purinergic receptor-dependent signal- 
ing mechanism. Our results suggest that CFTR func- 
tions to regulate other Cl- secretory pathways in addi- 
tion to itself conducting CI-. 
Introduction 
P. M. Quinton discovered that secretory epithelia derived 
from cystic fibrosis (CF) patients have low CI- conductance 
(Quinton, 1983). Subsequent identification and cloning of 
the CF gene (Rommens et al., 1989; Riordan et al., 1989) 
led to many studies that demonstrated convincingly that 
the cystic fibrosis transmembrane conductance regulator 
(CFTR) is a linear, cAMP-activated 8-10 pS chloride chan- 
nel (Cliff et al., 1992). 
It is also known that, in addition to functioning as a CI- 
channel, CFTR controls the regulation of other transport 
pathways (Egan et al., 1992; Gabriel et al., 1993; Schwie- 
bert et al., 1994a). For example, patients with CF, and the 
CF (-/-) mouse, have enhanced Na ÷ absorption (Grubb 
et al., 1994; Chinet et al., 1994; Hyde et al., 1993; Alton 
et al., 1993); this enhanced Na ÷ absorption is corrected 
by addition of a wild-type copy of CFTR (Johnson et al., 
1995; Hyde et al., 1993; Alton et al., 1993). These data 
suggest that CFTR can interact with Na+-reabsorptive 
pathways. Likewise, in cells from CF patients, several lab- 
oratories showed that protein kinase A (PKA) regulation 
of outwardly rectifying CI- channels (ORCCs) is defective 
compared with that of normal epithelia. Complementation 
of CF airway epithelial cells with the wild-type CF gene 
corrects PKA regulation of ORCCs (Egan et al., 1992; Ga- 
briel et al., 1993; Schwiebert et al., 1994a). The biophysical 
properties of ORCCs, which include a large conductance 
(30-70 pS), a rectifying current-voltage (I-V) relationship, 
sensitivity to 4,4'-diisothiocyanotostilbene-2,2'-disulfonic 
acid (DIDS), activation with depolariz!ng voltages, and a 
halide permselectivity of I- > CI- differ completely from 
CFTR channel properties (Hwang et al., 1989; Egan et 
al., 1992; Gabriel et al., 1993; Schwiebert et al., 1994a). 
Evidence suggests that CFTR and ORCCs are encoded 
by separate genes (Gabriel et al., 1993). Finally, it has 
been demonstrated that Ca2+-dependent CI- secretion is 
also up-regulated in CF patients and in the CF (-/-) mouse 
(Grubbet al., 1994). This up-regulation of the Ca 2÷- 
dependent pathway is also corrected by wild-type CFTR 
transduction (Johnson et al., 1995). Clearly, CFTR can con- 
trol the function of both Na ÷ and CI- transport pathways. 
Although it is known that CFTR can influence the regula- 
tion of distinct channel .types, their activity, or both, the 
question regarding the cellular mechanisms involved is 
unanswered. Several hypotheses that explain how CFTR 
might control ORCCs include direct protein-protein i ter- 
action, activation of a shared second messenger pathway, 
or the transport of a substance that could activate ORCCs. 
The purpose of this study was to define the cellular mecha- 
nisms whereby CFTR regulates ORCCs. Our results sug- 
gest that CFTR regulates ORCCs by triggering the trans- 
port and release of the potent autacoid agonist and ORCC 
regulator ATP. 
Results 
. j  
Dependence of cAMP Activation of ORCCs on 
Intracellular ATP 
Previously, we showed that 5 mM intracellular Mg2+-ATP 
was required to maintain cAMP stimulation of ORCCs dur- 
ing whole-cell current recording and to prevent rundown 
or inactivation of ORCCs (Schwiebert et al., 1994a; 
Quinton and Reddy, 1992). As illustrated in Figure 1A, the 
degree of outward rectification and the magnitude of the 
cAMP-activated CI- currents (Ic~(cAMp)) become larger with 
increasing concentrations of intracellular (pipette) ATP in 
whole-cell patch-clamp recordings of normal airway epi- 
thelial (9HTEo-) cells prestimulated in all cases with 8-(4- 
chlorophenylthio)-adenosine-3',5'.cyclic monophosphate 
(CPT-cAMP) (200 I~M). This airway epithelial cell line has 
been used previously to study the wild-type properties of 
CFTR (Schwiebert et al., 1994a). At 1 mM intracellular 
Mg2÷-ATP, IC~<cAMPI currents are linear (Figure 1A). A con- 
centration of at least 2.5 mM intracellular Mg2+-ATP is 
necessary to begin to observe rectifying currents. At 5 
mM or 10 mM intracellular Mg2+-ATP, cAMP-stimulated 
currents are clearly rectifying (Figure° 1A). Outward rectifi- 
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Figure 1. cAMP Stimulation of ORCCs Requires Physiological (5 mM) 
Intracellular Mg-ATP 
(A) I-V plots from whole-cell patch-clamp experiments performed on 
normal airway epithelial (gHTEo-) cells at 35°C in symmetrical 145 
mM Tris-CI solutions. I-V plots of IC,(cAMP) with 1 mM Mg-ATP in the 
pipette solution (n = 6; open circles); 2.5 mM Mg-ATP (n = 5; closed 
circles); 5 mM Mg-ATP (n = 10; open triangles); 10 mM Mg-ATP 
(n = 6; closed triangles). Basal currents were recorded before stimula- 
tion with CPT-cAMP (200 ~M) and were minimal (see basal current 
record, Figure 2A). Steady-state I-V relationships are plotted in all 
I-V plots in this and all figures. 
(B) I-V plots showing inhibition by TS-TM-Calix4 (10 nM; n = 3) of 
th?._outwardly rectifying portion of IC,(cAMP> with 5 mM pipette Mg-ATP 
and complete inhibition by glybenclamide (100 p_M) pretreatment of 
IC,(~AMP) (n = 5). Data are expressed as mean _+ SEM. 
cation of ICKcAMP)is inhibited markedly by 5,11,17,23-tetra- 
sulfonato-25,26,27,28-tetramet hoxy-calix[4]arene (TS-TM- 
calix[4]arene or TS-TM-Calix4) (Figure 1B); ORCCs but 
not CFTR are inhibited by this CI- channel-b locking drug 
(Singh et al., 1993; Schwiebert et al., 1994a). Interestingly, 
pretreatment of normal cells with glybenclamide, a CI- 
channel inhibitor specific for CFTR (Sheppard and Welsh, 
1993), blocked cAMP stimulation of both CFTR and 
ORCCs (Figure 1B). CPT-cAMP stimulation of rectifying 
currents does not occur either in IB3-1 CF bronchial epi- 
thelial cells or in ECFTE-29o- CF tracheal epithelial cells 
(n = 5-10 each; data not shown). Therefore, these data 
show that cAMP stimulation of ORCCs is dependent upon 
intracellular ATP and upon the expression of wild-type 
CFTR. 
Effects of Extracellular ATP Trapping on cAMP 
Activation of ORCCs 
To test the hypothesis that ATP acts extracellularly in 
cAMP stimulation of ORCCs, whole-cell recordings were 
performed in the absence and presence of the ATP scav- 
enger hexokinase in cells containing wild-type CFTR. Hexo- 
kinase traps ATP in solution by cleaving the y-phosphate 
of ATP and donating it to glucose, creating the end product 
glucose-6-phosphate. Glucose was present in all bath so- 
lutions. In the absence of hexokinase but with 5 mM Mg-  
ATP in the pipette and CPT-cAMP in the bath, IC,(cAMP) is 
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Figure 2. ATP Trapping Blocks cAMP Stimulation of ORCCs 
(A) Representative whole-cell current recordings and corresponding 
I-V plots from normal airway epithelial (9HTEo-) cells before (basal) 
and after addition of CPT-cAMP (200 p.M; CPT-cAM P), and after addi- 
tion of CPT-cAMP in the presence of hexokinase (0.5 U/ml; CPT- 
cAMP plus HK). Current and time scales and a voltage pulse protocol 
are shown. 
(B) Left bar graph illustrating cAMP-activated whole-cell CI conduc- 
tance (Gc,~cAMP)) at -100 mV and +100 mV command voltages in normal 
cells. Basal currents were minimal and were subtracted from cAMP- 
stimulated currents to graph GC,icAMP). The bar graph on the right sum- 
marizes results from IB3-1 cells transiently transfected with wild-type 
CFTR; results from nonresponding cells and responding cells with 
and without hexokinase are shown. Greater GC~(oAMP) at +100 mV when 
compared with GC,(cAMP) at -100 mV reflects outward rectification of 
GC,IcAMP). AS expected, 5 mM ATPyS with CPT-cAMP and 5 mM pipette 
Mg-ATP also failed to stimulate GCI in CF airway epithelial cells (data 
not shown). Data are expressed as mean _+ SEM. Asterisk, P < 0.05 
when compared with response from CF cells; two asterisks, P < 0.05 
refers to significant outward rectification of GCJCoAMP). Millimolar concen- 
tration of ATP or ATP'yS in the pipette is shown as 5 ATP or 5 ATPTS; 
Glu, HK/Glu, and apyrase refer to glucose, hexokinase (HK), both 
glucose and hexokinase, or apyrase in the bath for a given set of data. 
The number in parentheses is the number of experiments performed. 
outwardly rectifying (Figures 2A and 2B). However, in the 
presence of bath hexokinase, IC,(cAMP) is l inear and time- 
and voltage-independent, consistent with stimulation of 
only CFTR CI- channels and not ORCCs (Figures 2A and 
2B). A different ATP scavenger, apyrase, an ATPase/ADP- 
ase isolated from potato, also prevented cAMP stimulation 
of ORCCs without affecting activation of CFTR currents 
(Figure 2B), suggesting that the effects of hexokinase and 
apyrase were due to ATP catalysis. When 5 mM ATPyS, 
a poorly hydrolyzable and hexokinase-resistant analog of 
ATP, was included in the pipette solution along with 5 mM 
Mg-ATP,  IC,(cAMP)in the presence of hexokinase became 
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Table 1. Incidence of PKA Stimulation of Single CFTR and 
ORCC Channels 
Incidence of PKA 
Stimulation 
Hexokinase in 
Pipette Solution CFTR (%) ORCC (%) n 
No hexokinase 9 of 10 (90) 5 of 10 (50) 10 
Hexokinase (0.2 U/ml) 8 of 10 (80) 0 of 10 (0)" 10 
Refers to significant difference between incidence of ORCC channels 
in the absence versus the presence of hexokinase in the pipette (extra- 
cellular) solution (P ~< 0.05; unpaired Student's t test analysis; Neu- 
man-Keul's test). Moreover, in 4 out of the 8 patches that contained 
activated CFTR channels in the presence of hexokinase, ORCCs were 
also present as determined by stimulation elicited by depolarization. 
These ORCCs were, however, insensitive to PKA and ATP stimulation. 
outwardly rectifying again (Figure 2B). Hexokinase was 
ineffective when glucose was omitted from the bath solu- 
tion (data not shown). As expected, the presence of hexo- 
kinase had no effect on the inability of cAMP to stimulate 
CI- currents in CF cells (n = 5; data not shown). These 
data show that lack of activation of ORCCs in the presence 
of hexokinase or apyrase was indeed caused by ATP trap- 
ping and suggest that release of ATP into the extracellular 
solution from the epithelial cells themselves is important 
for activating ORCCs during cAMP stimulation. Whole-cell 
current experiments performed in the presence and ab- 
sence of hexokinase in the bath on IB3-1 CF cells tran- 
siently transfected with wild-type CFTR gave similar re- 
suits (Figure 2B), el iminating the possibility that the 
hexokinase inhibition of cAMP-stimulated outwardly recti- 
fying currents is cell type-specif ic. 
To study the effects of hexokinase on single ORCCs, ex- 
cised, inside-out patch clamping was performed on IB3-1 
CF cells complemented with wild-type CFTR (clone $9). 
As shown previously by utilizing this wild-type CFTR- 
complemented IB3-1 cell line (Egan et al., 1992), catalytic 
subunit of PKA (50 nM) and Mg-ATP (1 mM) added to 
the bath solution (cytoplasmic face of excised patches) 
activated both CFTR CI- channels and ORCCs (Table 1). 
With hexokinase (0.2 U/ml) in the extracellular (pipette) 
solution, PKA and ATP activated only CFTR channels (Ta- 
ble 1); ORCCs were not activated in *any of the patches 
by PKA and ATP, although they were present in 4 out of 
10 patches as determined by activation with depolarization 
(Table 1). Neither CFTR nor ORCCs were activated in 
excised patches from IB3-1 CF cells not complemented 
with wild-type CFTR, although ORCCs were present in 5 
out of 10 patches (50%) as determined by depolarizing 
voltage pulse (data not shown). Taken together, these re- 
sults show that the trapping of the released ATP in extra- 
cellular solution by either hexokinase or apyrase dissoci- 
ates cAMP stimulation of CFTR from that of ORCCs in 
cells containing wild-type CFTR. 
Extracellular ATP Stimulation of ORCCs 
Because the previous experiments suggested a role for 
external ly released ATP in activating ORCCs, we explored 
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Figure 3. Stimulation of ORCCs by Nanomo- 
lar Doses of ATP as an Agonist 
(A) Representative cell-attached recording 
from an IB3-1 CF cell stimulated with 500 nM 
ATP as an agonist. Currentand time scale bars 
are shown. 
(B) Representative whole-cell recordings from 
a normal (9HTEo-) cell and a CF (]~CFTE-29o-) 
cell before (basal) and at peak stimulation of 
ICl(ATP)"after addition of 10 nM ATP (ATP 10 
nM). Current and time scales are shown. 
(C) Time courses illustrating the GCI(ATP) in 
the absence (left; n = 3) and presence (right; 
n = 3) of TS-TM-calix[4]arene (10 nM). 
GCI(ATP) (in nanosiemens; +100 mV com- 
mand voltage) is plotted as a function of time. 
ATP was added at the time indicated by the 
arrows at the nM dosages shown. Data are 
shown as mean _+ SEM. 
(D) Representative whole-cell recordings and 
corresponding I-V plots of current before addi- 
tion of 10 p.M ATP (basal) and at 1, 5, and 8 
min following addition of 10 p.M ATP. Multiple 
types of whole-cell CI- currents were stimulated 
by this dose of ATP in a time-dependent man- 
ner (n = 4). 
(E) Dose-response graph of GCI(ATP). Peak- 
stimulated GCI(ATP) (in nanosiemens; +100 
mV command voltage [Vc]; basal conductance 
was subtraeted from GCI(ATP)) is plotted as a 
function of ATP concentration for normal (9HTEo=) and CF (~CFTE-29o) cells. Data is shown as mean _+ SEM (n shown inside each bar). ATP 
was added to a static bath solution after recording of basal currents beginning always at a 1 nM dose, then 10 nM ATP, et cetera. 
(F) Peak nucleotide-stimulated GCI in normal (9HTEo) cells (basal conductance was subtracted from the experimental peak values) calculated 
at +100 mV Vc is shown. Each nucleotide (500 nM) was added to the bath solution; the effect was transient and was assessed for 8-10 min of 
recording. Data are shown as mean _+ SEM (n shown inside each bar). 
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in more detail the role of extracellular ATP in the activation 
of ORCCs by utilizing both cell-attached and whole-cell 
patch-clamp experiments. In cell-attached patches of CF 
cells complemented with wild-type CFTR ($9 cells), addi- 
tion of 500 nM ATP as an agonist into the pipette and bath 
(extracellular) solutions stimulated ORCC single channels 
in 4 out of 4 patches upon formation of the cell-attached 
patch (Figure 3A). The open probability (Po) of the ORCC 
channels 1 min after patch formation in the presence of 
500 nM ATPwas0.49 _.+ 0.11 (n = 4). In fiveother patches, 
no channel activity was observed; ORCCs were not con- 
tained in these patches, as determined by excision and 
depolarization. After 3 min, the Po decreased to 0.04 _+ 
0.03 (n = 4). ATP (500 nM) stimulates ORCCs specifically; 
no other channels where observed in these experiments. 
The reversal potential (Erev) of corresponding I-V plots con- 
structed from pipette voltages of ATP-stimulated ORCCs 
was +19.2 mV (the Nernst equations predict an E,ev of +32 
mV if the channel is completely selective for CI- and if 
intracellular CI- concentration is assumed to be 39 mM) 
(Welsh, 1986). Also assuming a resting membrane poten- 
tial of -46 mV (Welsh, 1986), the estimated and corrected 
Erev for ATP-stimulated ORCCs in cell-attached patches 
would be approximately -30 mV, consistent with stimula- 
tion of an ORCC CI- channel by 500 nM ATP. 
Extracellular ATP at nanomolar doses in the absence 
of cAMP also stimulated outwardly rectifying whole-cell 
CI- currents in both normal and CF cells (Figure 3B). Stimu- 
lation of outwardly rectifying whole-cell CI- currents by 
na~omolar doses of extracellu liar ATP was in hibited mark- 
edly by TS-TM-calix[4]arene, demonstrating that the cur- 
rents are generated specifically by ORCCs (Figure 3C). 
Stimulation of ORCCs with external ATP at 100 nM doses 
was biphasic, consisting of both transient and sustained 
components of stimulated current. At higher concentra- 
tions of extracellular ATP added to the bath solution, multi- 
ple types of whole-cell CI- currents were activated. Figure 
3D shows an example of at least three types of whole-cell 
CI- currents activated in a time-dependent manner by 10 
I~M ATP. Outwardly rectifying currents were activated ini- 
tially and were later masked by activation of linear and 
inwardly rectifying currents. Stimulation with micromolar 
doses of ATP also induced transient and sustained current 
responses. Because of the multiplicity of ATP-activated 
currents observed at the higher doses, we focused specifi- 
cally on the effects of lower dose (nanomolar) stimulation 
by ATP. 
ORCC currents in both normal and CF cells are activated 
equivalently by nanomolar doses of extracellular ATP (Fig- 
ure 3E). Therefore, unlike cAMP-dependent activation, 
which only occurs in the presence of wild-type CFTR, ex- 
ternal ATP stimulates ORCCs independently of CFTR. 
The stimulation of ORCCs by external ATP is most likely 
via a purinergic receptor expressed in the plasma mem- 
brane. To gain more information on which subtype of pu- 
rinergic receptor is involved in the stimulation of ORCCs, 
500 nM external ATP was compared with other nucleo- 
tides, such as GTP, AMP, ADP, ATPTS, and UTP, in 
whole-cell recordings of normal airway epithelial (9HTEo-) 
cells. Antagonists and agonists selective or specific for 
the five or more different subtypes of P2 purinergic recep- 
tors are not available (Barnard et al., 1994). A dose of 500 
nM was used, because this dose produced a potent yet 
specific stimulation of ORCC currents. Figure 3F shows 
that UTP, ATP, and ATPTS were equipotent, whereas 
other nucleotides were less effective. The rank order po- 
tency for stimulation of ORCC currents was UTP/> ATP 1> 
ATPyS >> ADP > AMP = GTP (Figure 3F). Addition of 
AMP and GTP produced no significant increase in whole- 
cell conductance (Figure 3F). This rank order of potency 
is most consistent with the affinity profile of a P2u purinergic 
receptor and suggests that ATP stimulates ORCCs via 
this purinergic receptor subtype (Lustig et a1.,o1993; Parr 
et al., 1994; Barnard et al., 1994). 
CFTR-Mediated ATP Transport 
To demonstrate directly that CFTR triggers the transport of 
ATP out of cells, two independent experimental pproaches 
were undertaken. First, excised, inside-out patch-clamp 
recordings of wild-type CFTR-complemented CF cells 
were studied to compare conduction of CI- anions with 
conduction of ATP- anions. PKA. and ATP-activated CFTR 
CI- channels had a conductance of 10 pS in symmetrical 
NaCI-containing solutions at both -50 mV and +50 mV. 
When the bath solution was switched to a Na2-ATP- 
containing solution ([ATP], 50 mM), the conductance of 
this CFTR channel decreased from 10 pS to 5 pS at -50 
mV (cytoplasmic side of the patch negative relative to the 
extracellular side of the patch), injected to drive anionic 
ATP from the cytoplasmic (bath) side of the membrane 
patch to the extracellular (pipette) side of the patch (Table 
2). At +50 mV, a 10 pS CI- conductance was still measured 
(Table 2). Moreover, when the bath solution was switched 
Table 2. Chloride and ATP Single-Channel Conductances 
through CFTR 
Pipette Bath y (-50 m~ y (+50 mV) 
NaCI NaCI 9.7 ± 0.4 9.7 ± 0.4 
NaCI Na2-ATP 5.1 ± 0.5 • 9.7 ± 0.4 
NaCI NaCI 9.7 ± 0.4 9.7 _ 0.4 
NaGlu Na2-ATP 5.1 ± 0.4 ~ No y 
Tris-CI Tris-ATP 5.6 ± 0.3 a 9.4 _ 0.3 
Tris-ATP Tris-ATP 5.7 ... 0.3 5.7 ± 0.3 
Data included in this table are the mean ± SEM of at least five experi- 
ments performed on excised, inside-out patches of the apical mem- 
brane of wild-type CFTR-complemented IB3-1 CF cells (clone $9) with 
each pipette and bath solution shown. The -50 mV voltage (cyto- 
plasmic side negative relative to the extracellular side of the patch) 
drives anions from the cytoplasmic (bath) side of the membrane patch 
to the extracellular (pipette) side of the patch. In each experiment, no 
channel activity was measured for at least 5 min following excision, 
whereas ubsequent addition of PKA and ATP opened these channels. 
CI- conductance issymmetrical Tris-CI solutions was 9.4 ± 0.26 pS, 
a value not different from NaCI-containing solutions. ATP conduc- 
tance in symmetrical Tris-ATP solutions was 5.7 ± 0.3 pS, a value 
significantly different from the 9.4 ± 0.26 p~ CI- conductance. 
7, single-channel conductance (in picosiemens). 
a Significant difference between ATP- conductance and CI- conduc- 
tance. 
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Figure 4. CFTRTriggersATPConductionand 
ATP Release in Airway Epithelial Cells 
(A) Representative single ATP- and CI- chan- 
nel currents from $9 cell membrane patch stim- 
ulated by PKA and ATP with Tris-CI in the pi- 
pette solution and Tris-ATP in the bath 
solution. 
(B) Corresponding I-V plot for the same chan- 
nel, where ATP- currents were observed at 
negative voltages and CI- currents at positive 
voltages (n = 9). The reversal potential of the 
measured current amplitudes was-22.0 _ 2.0 
mV (n = 5). An accompanying I-V plot for ATP- 
currents measured in symmetrical Tris-ATP is 
also shown. The I-V plot for CI- currents mea- 
sured in symmetrical Tris-CI was linear with a 
slope conductance of 9.~ pS (see Table 2 for 
conductance data). 
(<3) Bar graph illustrating percent cAMP-stimu- 
lated generation ofglucose-6--32P inIB3-1 cells, 
IB3-1 cells stably transfected with an AAV in- 
verted terminal repeat promotor-driven wild- 
type CFTR viral vector (Egan et al, 1992; Flotte 
et al., 1993; Schwiebert et al., 1994a), or IB3-1 cells transiently transfected with wild-type or mutant CFTR (A455E-CFTR and G551D-CFTR). Data 
are expressed to percent change versus control. Data are expressed as mean _ SEM. Number in parentheses i  number of experiments performed. 
back to a CI--containing solution, the conductance re- 
turned from 5 pS to 10 pS at -50 mV. Both the 10 pS CI- 
conductance and the 5 pS ATP 2- conductance were inhib- 
ited completely by glybenclamide (100 p.M, n = 3-5 each; 
Po decreased to 0.00). A 5 pS ATP conductance was also 
recorded with Naz-ATP ([ATP], 50 mM) in the bath and 
Na gluconate in the pipette solution (CI--free solutions in 
pipette and bath), but only at -50 mV, again designed to 
drive ATP anions from the cytoplasmic side of the patch 
to the extracellular side of the patch (Table 2). Correspond- 
ing I-V plots of the ATP current amplitudes how that no 
currents were measured at positive voltages, since only 
gtuconate was present on that side of the patch (data not 
shown). These currents are not carried by Na + for the fol- 
lowing reasons: first, Na ÷ concentrations are symmetrical 
in these CI--free conditions; second, such currents would 
be observed at both negative and positive voltages with 
similar amplitudes in these CI--free conditions; and third, 
the currents would be insensitive to glybenclamide. Also, 
similar differential conductances were observed in asym- 
metrical conditions with Tris-CI ([CI], 140 mM) in the pi- 
pette solution and Tris-ATP ([ATP], 140 mM) in the bath 
solution (Table 2). Figure 4A shows a single-channel cur- 
rent record that displays ATP- current amplitudes at -50 
mV and CI- current amplitudes at +50 mV voltage in these 
asymmetrical conditions. The corresponding I-V plot illus- 
trates the ATP- current amplitudes at negative voltages 
and the CI- current amplitudes at positive voltages (Figure 
4B). The reversal potential (Erev) under these asymmetrical 
solutions was -22.0 _+ 2.0 mV, consistent with CI- being 
more permeable across the membrane patch. A linear 
I-V plot for ATP- currents was measured in symmetrical 
140 mM Tris-ATP (Figure 4B). These results, in particular, 
also illustrate relative CI- versus ATP- conductances 
across the patch, which were 9 pS and 6 pS respectively 
(Table 2). Finally, in symmetrical Tris-ATP solutions, the 
conductance was 6 pS at both -50 mV and +50 mY, con- 
sistent with the ATP- conductance measured in asymmet- 
rical Tris-CI/Tris-ATP (Table 2). 
Second, to demonstrate that cAMP-dependent ATP re- 
lease occurs from cells containing CFTR, IB3-1 CF cells 
or IB3-1 cells stably or transiently transfected with wild- 
type or mutant CFTR were loaded with high specific activ- 
ity [.),-32P]ATP by use of a 15 min streptolysin O (1 U/ml) 
permeabilization procedure followed by vigorous washing 
and a 2 hr incubation with ['),-32P]ATP in a standard Ring- 
er's solution (see Experimental Procedures). Release of 
[7-32P]ATP into the medium was measured over time with 
and without CPT-cAMP in Ringer's solution'that contained 
hexokinase (1 U/ml) to trap the [7-32P]ATP as glucose- 
6-32P. ATP release was stimulated by cAMP in cells either 
stably complemented (clones $9, 315A, and 6-wt-1) or 
transiently transfected with wild-type CFTR (Figure 4C). 
No cAMP-stimulated ATP release was observed in paren- 
tal IB3-1 CF cells (Figure 4C). Glybenclamide (100 pM) 
inhibited completely cAMP-stimulated ATP release from 
stably complemented 315A cells (Figure 4C). Interest- 
ingly, two mutations located in the first nucleotide-binding 
domain of CFTR, A455E-CFTR, a mutation associated 
with mild CF pulmonary disease, and G551 D-CFTR, a mu- 
tation associated with severe CF lung disease, had differ- 
ent effects on the ability of CFTR to trigger ATP release. 
IB3-1 CF cells transiently transfected with A455E reestab- 
lished cAMP-stimulated ATP release, although the mag- 
nitude was not as large compared with wild-type CFTR 
(Figure 4C). In sharp contrast, G551D failed to comple- 
ment cAMP-stimulated ATP release in IB3-1 CF cells (Fig- 
ure 4C). 
Taken together, these data show that cells containing 
a wild-type copy of CFTR can release ATP in response 
to cAMP either through CFTR or via a closely associated 
ATP channel and that this release mechanism does not 
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Figure 5. ORCCs as Well as CFTR Contribute to cAMP- and ATP- 
Stimulated CI Secretion 
(A) Short-circuit current races from a representative monolayer, show- 
ing the response to cAMP in the absence (upper left) and presence 
(lower left) of hexokinase (5 U/ml) pretreatment, cAMP stimulation in 
the presence and absence of hexokinase was performed on each 
monolayer; thus, the comparison of both conditions was paired. The 
response to cAMP was fully reversible. The effect of hexokinase when 
added at 2 rain (upper right) following cAMP stimulation is also shown. 
All experiments were performed in the presence of mucosal amiloride 
(10 IIM). The bar graph (lower right) illustrating percent inhibition of 
cAMP-stimulated I~ with hexokinase in the mucosal solution is also 
shown. Asterisk indicates significant inhibition (P < 0.05). 
occur in CF cells that contain CFTR bearing either AF508 
(mutation in parental IB3-1 cells) or G551D mutations. 
Role of ATP in a Polarized Epithelium 
To determine whether ATP release can play a role in CI- 
secretion in a polarized epithelium and to evaluate the 
role for ORCCs in CI- secretion, short-circuit current (1~) 
recordings were performed on normal rat tracheal epithe- 
lial cells grown in primary culture on permeable supports. 
All experiments were performed in the presence of apical 
amiloride (10 p,M). Basolateral addition of 8-bromo-cAMP 
(200 I~M) increased I~ (Figure 5A) in a monophasic man- 
ner, as expected for these normal airway epithelial cells. 
Pretreatment with hexokinase (5 U/ml; 5 mM glucose is 
present in the bath solution, pre-cAMP in Figure 5A) added 
to the apical solution, however, attenuated cAMP stimula- 
tion of I~ by 40.0% ± 7.7% (n = 9). Hexokinase added 
to the serosal solution had no effect on cAMP stimulation 
of Isc (data not shown). Addition of hexokinase following 
cAMP stimulation (post-cAMP, Figure 5A) inhibited I~ by 
31.0% ± 3.2o/0 (n = 8). The hexokinase-insensitive I~ 
was inhibited completely by glybenclamide (100 I~M; Fig- 
ure 5A). 
Several CI- Pathways Contribute to cAMP-and 
ATP-Stimulated CI- Secretion 
To evaluate the contribution of individual CI- secretory 
pathways in cAMP-stimulated and ATP-stimulated CI- se- 
cretion, the effect of CI- channel-blocking agents selective 
for CFTR (glybenclamide) (Sheppard and Welsh, 1993), 
selective for ORCCs (TS-TM-calix[4]arene, DIDS) (Singh 
et al., 1993; Schwiebert et al., 1994a; Cliff et al., 1992), 
or selective for both CFTR and ORCCs (diphenylamine 
carboxylic acid [DPC]) (Cliff et al., 1992; Schwiebert et al,, 
1994a) was examined. 
Pretreatment of rat tracheal epithelial monolayers with 
g lybenc lamide (100 I~M) or DPC (5 mM) complete ly  
blocked cAMP-stimulated I,c (Figure 5B). In contrast, com- 
ponents of the cAMP-stimulated Isc were inhibited either 
by TS-TM-calix[4]arene (21%, 1 ~M)~or DIDS (310/0, 1 mM) 
with subsequent addition of glybenclamide inhibiting the 
remaining portion (66%, Figure 5B). Complete inhibition 
with glybenclamide pretreatment is consistent with whole- 
cell patch-clamp experiments (see Figure 1B) and sug- 
(B) Representative short-circuit current recordings illustrating sensitiv- 
ity of cAMP-stimulated I~ to DIDS and to glybenclamide and bar graph 
summary of results with CI- channel inhibitors. In the upper right panel 
of (A), the differential effects of TS-TM-calix[4]arene and glybencla- 
mide are shown as well. I~ with 8-Br-cAMP was 47.8 _+ 1 t .6 p.Ncm 2 
(n = 12). The summary reflects results from maximal doses of DPC 
(5 raM), glybenclamide (100 p.M), TS-TM-Calix4 (1 p.M), and DIDS (1 
raM). Asteris k indicates significant inhibition (P < 0.05). 
(C) Short-circuit current traces from representative monolayers illus- 
trating dose-response of apically-added ATP in the absence (upper 
trace) and presence (lower trace) of DIDS (1 mM). Bar graph summary 
of results of ATP-stimulated peak currents (open bars) and sustained 
currents (solid bars) and sensitivity of the sustained currents to TS-TM- 
calix[4]arene (1 p.M) and DIDS (1 raM) is also shown below. The inset 
figure illustrates inhibition of ATP-stimulated I,o by TS-TM-calix[4]arene 
(1 I~M). Asterisk ind icates significant stimulation or inhibition (P < 0.05). 
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Figure 6. Model of CFTR-ORCC Regulatory Interaction 
Model illustrating how CFTR regulates ORCCs through triggering the 
transport and release of the agonist ATP. The bold arrow through 
CFTR refers to the well-known CI- channel activity of CFTR, whereas 
the open arrow through CFTR refers to cAMP-stimulated and CFTR- 
dependent ATP release. The G refers to the unknown G protein that 
couples the receptor to the ORCC or to an unknown, membrane- 
delimited signaling pathway that stimulates ORCCs. Asterisk refers 
to CFTR- and cAMP-dependent ATP movement across the membrane. 
gests that this inhibitor disrupts both CFTR CI- channel 
function and cAMP- and CFTR-dependent ATP release. 
Indeed, glybenclamide also inhibited ATP conductance 
(see above) and ATP release (see Figure 4C). 
As observed in whole-cell patch-clamp experiments, as 
little as 1-10 nM ATP added to the apical side of mono- 
layers stimulated I~; ATP increased I.c in these monolayers 
in a dose-dependent manner between 100 nM and 5 ~M 
(Figure 5C). This activation was biphasic, consisting of 
transient and sustained components (Figure 5C). Of inter- 
est, the response was less robust at 50 I~M (Figure 5C). 
Addition of DIDS (1 mM) or TS-TM-calix[4]arene (1 pM) 
blocked almost completely the sustained current after ATP 
stimulation (Figure 5C). Pretreatment with DIDS, however, 
completely blocked responses to nanomolar doses of ATP 
but only partially inhibited responses to micromolar doses 
of ATP. The DIDS-insensitive component of Isc was inhib- 
ited completely by glybenclamide (100 I~M). 
These results show that a portion of cAMP-dependent 
CI- secretion is inhibited by hexokinase and depends upon 
the release of ATP as an autocrine or paracrine agonist. 
The results also show that several apical CI- secretory 
pathways contribute to cAMP- and to ATP-stimulated CI- 
secretion in rat tracheal epithelium; these include glyben- 
clamide, TS-TM-calix[4]arene, and DIDS-sensitive com- 
ponents. Importantly, when stimulated by nanomolar 
doses of ATP, the TS-TM-calix[4]arene- and DIDS-sensi- 
tive components predominate. Taken together with the 
data from single-channel and whole-cell patch-clamp ex- 
periments, these data are consistent with involvement of 
multiple channel types, including ORCCs, in CI- secretion 
in the airway and demonstrate that ORCCs are physiologi- 
cally relevant to airway surface epithelial CI- secretion. 
Discussion 
Initial hypotheses on the function of CFTR, the cystic fibro- 
sis transmembrane conductance regulator, shortly after 
the CF gene was cloned and sequenced suggested that 
the CF gene product may function as a conductance regu- 
lator. Our data are consistent with the cellular model, 
shown in Figure 6, of how CFTR is a regulator of multiple 
CI--secretory pathways. Cyclic AMP- and PKA-stimulated 
CFTR, in addition to conducting CI- ions, either conducts 
ATP out of the cell, down a favorable concentration gradi- 
ent, or regulates a closely associated ATP release chan- 
nel. Once released from the cell, ATP as an agonist stimu- 
lates ORCCs through activation of P2u purinergic receptors. 
Activated P2u purinergic receptors, either through direct 
coupling to the ORCC or through a G protein-coupled 
signaling pathway, stimulate ORCCs and, most likely, 
other CI- channels to conduct more Cl-oions out of the cell 
into the airway. 
A key observation is that ATP scavengers such as hexo- 
kinase and apyrase inhibit very effectively cAMP and PKA 
activation of outwardly rectifying whole-cell CI- currents 
and single-channel events and a component of CI- secre- 
tion in a tracheal epithelium expressing wild-type CFTR. 
The inhibition of ORCC activation by these agents occurs 
without any effect on CFTR-driven currents. Thus, extra- 
cellular ATP scavengers dissociate cAMP activation of 
CFTR from ORCCs. A lack of activation of ORCCs by 
PKA had only been noted previously in the presence of 
AF508-CFTR in CF airway epithelia (Egan et al., 1992) or 
in CF ( - / - )  mouse airway epithelia (Gabriel et al., 1993). 
The observation that extracellular hexokinase can convert 
ORCCs from a PKA-sensitive mode to one that is PKA- 
insensitive in the continued presence of wild-type CFTR, 
a result similar to that observed previously only in CF cells, 
points strongly to a role of extracellular ATP, released by 
the epithelium itself, in this process. 
It is well known that ATP, presumably via a purinergic 
receptor in the apical cell membrane, can stimulate CI- 
secretion in both CF and normal epithelia when applied 
in micromolar concentrations (Knowles et al., 1991; Clarke 
and Boucher, 1992). Experiments in this study have pro- 
vided both additional and novel results to show that nano- 
molar concentrations of extr~cellular ATP and other nucleo- 
tides (UTP, ATP~,S) can stimulate ORCCs in normal and 
CF airway epithelial cells. In addition, larger doses of ATP 
(10 ~M) stimulated ORCCs as well as other CI- conduc- 
tances in a time-dependent manner. These results agree 
with those of Stutts and coworkers, who have shown stimu- 
lation of multiple conductances by ATP at doses between 
100 p.M and 1 mM (Stutts et al., 1994). The profile of po- 
tency of individual nucleotides, especially the similar po- 
tency of UTP and ATP, suggests that a P2u or P2¥2 subtype 
of purinergic receptor plays a role (Lustig et al., 1993; 
Barnard et al., 1994) in the apical membrane of human 
airway epithelia. ATP activation of ORCCs was demon- 
strated in whole-cell and single-channel patch-clamp re- 
cordings with cytoplasmic Ca 2÷ buffered to 100 nM; it is 
unlikely that signal transduction pathways involving an in- 
crease in intracellular Ca 2÷ mediate the response in patch- 
clamp experiments. It is possible, however, that Ca2+~, at 
least in part, is responsible for ATP stimulation of secretory 
CI- current in short-circuit current experiments. 
Our results pointing to a regulatory role for external ATP 
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raise the question of the source of external ATP. In all 
experimental assays, the only source of ATP is the epithe- 
lial cells themselves, unless ATP is added as an agonist 
artificially. As early as 1986, the biological activity of ATP 
as an agonist had already been studied extensively and 
reviewed (Gordon, 1986). In this study, we have also dem- 
onstrated that airway epithelial cell lines containing a nor- 
mal copy of CFTR can promote the release of ATP upon 
stimulation by cAMP. This cAMP-stimulated ATP release 
is inhibited completely by glybenclamide, a CFTR channel 
inhibitor, and does not occur in CF epithelial cells, sug- 
gesting an involvement of CFTR itself in the ATP release 
mechanism or CFTR regulation of a closely associated 
ATP release channel. Further support for this hypothesis 
is that CFTR bearing an A455E mutation, which is associ- 
ated with mild CF lung disease, can induce ATP release, 
whereas CFTR bearing a more severe G551D mutation 
fails to trigger ATP release. In a separate study, it was 
shown that both of the mutant forms of CFTR, A455E and 
G551D, could function as cAMP-activated CI- channels, 
although the function of G551D was much reduced com- 
pared with that of wild-type or A455E CFTR (Fulmer et 
al., 1995). Importantly, only A455E and not G551D could 
correct cAMP regulation of ORCCs in IB3-1 CF cells 
(Fulmer et al., 1995). This result suggests that the ability of 
CFTR to form a CI- channel does not necessarily correlate 
with its ability to induce ATP release or perform its conduc- 
tance regulator functions. 
The possibility that CFTR could be involved in ATP re- 
I~ase from cells was proposed first by H. F. Cantiello and 
collaborators (Reisin et al., 1994). In this study, we pro- 
vided additional evidence that CFTR can either conduct 
ATP or affect the release of ATP from the cell by regulating 
an ATP release mechanism. For example, in excised 
patch-clamp recordings of single CFTR CI- channels, sin- 
gle-channel events can be observed with ATP- as the only 
permeant anion on the cytoplasmic side of a patch, which 
in CI--containing solutions was verified to possess only 
CFTR CI- channels. Both CFTR CI- and ATP- single- 
channel conductances are blocked completely by glyben- 
clamide. ATP single-channel conductance through CFTR 
channels was approximately 6 pS, in agreement with the 
value derived from previous experiments (Reisin et al., 
1994). Moreover, the design of the CI--free patch-clamp 
experiment and results from experiments in Tris solutions 
suggest that anionic conductances are being measured 
in these experiments. Clearly, the simplest interpretation 
is that CFTR itself can conduct ATP; however, it is also 
possible that, through its role as a conductance regulator, 
CFTR can affect the release of ATP through a closely 
related but separate channel. 
By transporting CI- itself and by activating other CI- 
channels, CFTR could magnify its role in CI- secretion 
despite its low expression in airway surface epithelia (Chu 
et al., 1991). Finally, the role of CFTR as a conductance 
regulator may also explain why only a relatively small 
amount of wild-type CFTR is necessary to achieve a clini- 
cally normal CI- secretory phenotype in the airway (Chu 
et al., 1991). Since only low levels of CFTR need to be 
expressed to achieve normal function, this observation 
has important implications for the level of expression nec- 
essary for gene therapy approaches to be efficacious 
along the airway. Although it is clear that extracellular ATP 
can activate ORCCs and other channels, that CFTR plays 
a role either direct or regulatory in the release of ATP, and 
that the two functions and channels are linked, it is likely 
that additional mechanisms may also participate in the 
interaction of CFTR and other transport processes in se- 
cretory epithelia. 
Experimental Procedures 
Cell Culture 
All studies were performed on human airway epithelial cell lines char- 
acterized and utilized for physiology in previous studies (Gruenert et 
al., 1988; Schwiebert et al., 1992; Schwiebert et al., 1994a; Schwiebert 
et al., 1994b; Egan et al., 1992; Kunzelmann et al., 1993; Zeitlin et 
al., 1991). 9HTEo- cells are a normal tracheal epithelial cell line that 
expresses wild-type CFTR (Gruenert et al., 1988; Schwiebert et al., 
1992; Schwiebert et al., 1994b; E. M. S., M. M. Morales, and W. B. G., 
unpublished ata). ]~CFTE-29o- cells are a CF human tracheal epithe- 
lial cell line derived from a CF patient homozygous for the ~,F508 
mutation (Kunzelmann et al., 1993). Each cell line was cultured as 
described previously in detail (Gruenert et al., 1988; Kunzelmann et 
al., 1993). IB3-1 cells are a CF human bronchial epithelial cell line 
derived from a CF patient compound heterozygous for the AF508 
mutation (~F508/W1282X) (Zeitlin et al., 1991; Egan et al., 1992). 
IB3-1 cells were grown as described previously in a modified LHC-8 
medium (Zeitlin et al., 1991; Egan et al., 1992). 
Stable Transfection 
DNA transfection of IB3-1 cells using lipofectin reagent (GIBCO BRL, 
Grand Island, NY) has been described previously in detail (Egan et 
al., 1992). Both clones 315A and $9 were established with this method 
using adeno-associated viral (AAV) vectors containing the full-length, 
wild-type CFTR cDNA (Egan et al., 1992; Flotte et al. 1993). 
Transient Transfection 
Transient transfection of IB3-1 cells was achieved by using a Rous 
sarcoma virus (RSV) promoter-driven mammalian expression vector 
(pAvS6-wtCFTR) containing the wild-type CFTR cDNA or with a second 
generation RSV vector (pRSV-wtCFTR) and lipofectin reagent. Both 
CFTR-containing RSV vectors complemented successfully cAMP- 
stimulated ~CI- efflux from IB3-1 CF cells (Fulmer et al., 1995). Lipo- 
fection was performed according to the guidelines of the manufacturer, 
with the only modification being continued incubation of DNA-lipofec- 
tin complexes in medium containing serum overnight following the 8 
hr incubation in serum-free conditions (Fulmer et al., 1995). 
Whole Cell Patch-Clamp Recording 
Whole-cell patch-clamp recording was performed as described pre- 
viously in detail on airway epithelial cells grown on glass coverslips 
(3 mm diameter; Bellco Glass, Vineland, NJ) coated with Vitrogen 
(human collagen, Collagen Corporation, Palo Alto, CA) under the con- 
ditions described above. In these recordings, the bath solution con- 
tained 145 mM Tris-HCI, 1 mM CaCI2, 1 mM MgCI2, 5 mM glucose, 
60 mM sucrose, and 5 mM N-2-hydroxyathylpiperazine-N'-2-ethane- 
sulfonic acid (HEPES; pH 7.45), and 0.2 ~m filtered. The pipette solu- 
tion contained Tris-HCI (145 raM), HEPES (5 raM), Ca 2+ and Mg2÷ (100 
nM each chelated with 2 mM EGTA), and Mg2+-ATP (pH 7.45), and 
0.2 ~m filtered. These solutions were designed to study only current 
flowing through CI- channels, since CI- was the only significant perme- 
ant ion in solution (Schwiebert et al., 1994a), to clamp intracellular 
Ca 2+ at approximately 100 nM, and to prevent swelling-activated CI- 
currents with added sucrose in the bath solution (Worrell et al., 1989). 
Single-Channel Patch-Clamp Recording 
Single-channel patch-clamp recordings were carried out in the excised 
inside-out patch-clamp configuration by using conventional proce- 
dures (Hamill et al., 1981; Egan et al., 1992). Catalytic subunit of PKA 
(50 nM; Promega, Madison, WI) and Mg-ATP (1 mM; Sigma, St. Louis, 
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MO) were added to the cytoplasmic face of excised patches to activate 
the channels. All single-channel patch-clamp studies were performed 
at 25°C, since previous studies have shown that spontaneous activa- 
tion of ORCCs does not occur at this temperature with patch excision 
(Egan et al., 1992). Cell-attached recording was also carried out with 
the pipette solution (see below) being present in pipette and bath but 
with 500 nM Mg2+-ATP in both pipette and bath solutions as an agonist. 
Recording was begun immediately after formation of the cell-attached 
patch. Integrity of the cell-attached patch was confirmed by visualizing 
the membrane patch ripping away from the cell as the patch was 
excised to form the inside-out configuration. Currents were amplified 
with an Axopatch 200A patch-clamp amplifier and recorded on video- 
tape for later analysis. Data were low-pass filtered at 500 Hz and digi- 
tized at 1 kHz. Data were analyzed with pCLAMP 5.5.1 software. The 
bath solution contained 141 mM NaCI, 2 mM MgCI2, 1 mM EGTA, 5 mM 
HEPES, and 0.5 mM CaCI2 (free Ca 2+ is 110 nM measured by Fura-2) 
(pH 7.3), 0.2 ~m filtered. The pipette solution contained 141 mM NaCI, 
2 mM CaCI2, 2 mM MgCI2, 5 mM HEPES, 5 mM glucose (pH 7.3), 0.2 
p.m filtered. 
For single-channel recordings of ATP- versus CI- currents, standard 
141 mM NaCI bath solution was exchanged for a nominally Cl=-free 
Na2-ATP solution that contained 40 mM Na gluconate, 50 mM Na2- 
ATP, 0.25 mM Ca gluconate, 1 mM EGTA, 5 mM HEPES (pH 7.4). 
For complete limination of CI- in pipette and bath solutions, the pipette 
solution was 140 mM Na gluconate, 0.5 mM Ca gluconate, 5 mM 
HEPES (pH 7.4). For elimination of Na ÷ from the solutions, 140 mM 
Tris-CI and 140 mM Tris-ATP were substituted for NaCI (all other 
constituents were similar). 
Short-Circuit Current Recording 
For short-circuit current experiments, rat tracheal epithelial cells were 
isolated by a three-step process. First, tracheas were excised surgi- 
cally from anesthetized rats. Second, excised tracheas were fileted 
open, and the tissue was subjected to 0.1% protease (Sigma) digestion 
overnight at 4°C with gentle agitation. Third, epithelial cells were 
scraped off the fileted tracheas, recovered by centrifugation, washed 
several times, resuspended as a homogeneous uspension in a modi- 
fied LHC-8 medium (Biofluids, Rockville, MD) containing 5% fetal bo- 
vine serum (GIBCO BRL), and seeded onto collagen gels or onto per- 
meable filters (12 mm SnapWell Transwell filter-bottom cups, Costar) 
for primary culture. The cultures were fed daily on the basolateral 
side of the monolayer, while the apical side was left exposed to the 
humidified, 50/0 CO2 environment. Confluence was achieved 3-4 days 
after initial seeding, and the monolayers were studied after 6-10 days 
in culture. Transepithelial resistances (RTE) were measured with an 
EVOM meter (World Precision Instruments, Sarasota, FL) and by cal- 
culating the resistance on the basis of measurement of basal transepi- 
thelial current and voltage after mounting the monolayer into the Uss- 
ing chamber. RTE ranged routinely from approximately 1000 to 2000 
Q/cm 2 for cells grown on either collagen gels or filter supports. RTE 
was also routinely judged to be optimal once medium no longer leaked 
across the monolayer to the apical side devoid of medium. 
The bath solution during Ussing chamber recordings was warmed 
to 37°C and contained 140 mM NaCI, 5 mM K2HPO4, 0.5 mM KH2PO4, 
1.2 mM CaCI2, 1.2 mM MgCI2, 5 mM HEPES, 5 mM glucose (pH 7.4). 
Ag-AgCI wires embedded in 3 M KCI-agar bridges were used as volt- 
age and current electrodes on each side of the monolayer contained 
in a perfused Ussing chamber system (World Precision Instruments), 
and voltage was clamped by a DVC-1000 voltage-clamp amplifier 
(World Precision Instruments) with a digital current and voltage readout 
and was attached to a strip-chart recorder for generation of real-time 
current traces. 
[y-32P]ATP Release Assay 
[y-~P]ATP (3000 Ci/mmol specific activity; 0.5 mCi per 6-well plate; 
New England Nuclear-DuPont) was loaded into cells via a three-step 
protocol: first, 15 min permeabilization with Streptolysin O (1 U/ml; 
Sigma) in a buffer containing 140 mM NaCI, 100 mM piperazine-N,N'- 
bis(2-ethanesulfonic acid) (PIPES), 5 mM glucose, 2.7 mM KCI, 2.7 
mM EGTA, 1 mM Na2-ATP (pH 7.4), with 0.1o/0 bovine serum albumin 
and 0.25 mCi of [y-32P]ATP; second, three 5 min washes with a Ringer's 
solution containing 140 mM NaCI, 1.5 mM CaCI2, 1 mM MgCI2, 5 mM 
HEPES, 5 mM glucose, 5 mM K2HPOJKH2PO4, (pH 7.4); and third, 
2 hr incubation in the same Ringer's solution with another dose of 0.25 
mCi of [y-~P]ATP. Before starting release assay time course, cells 
were washed five times with ice-cold Ringer's. Ringer's warmed to 
37°C with or without CPT-cAMP and always with 1 U/ml hexokinase 
to trap [y-32P]ATP as glucose-6-~2P was added at time 0 rain and ex- 
tracted at four time points between 0 and 10 min. The four samples 
were pooled and normalized as counts referable to generation of glu- 
cose-6-~P. To determine the percent of counts referable to generated 
glucose-6J2p, free phosphate or labeled phospholipids were trapped 
from samples with an equal volume (1 ml) of 50/0 (wt/vol) ammonium 
molybdate in 0.85 N sulfuric acid and extracted with an equal volume 
of butanol, and the aqueous phase was counted and compared with 
unextracted samples (Ambudkar and Maloney, 1984). Reproducibly, 
75%-80% of the counts after extraction remained as glucose-6- 
phosphate. Alternatively, samples from a separate series of experi- 
ments were repeated in cells loaded with [7-~P]ATP but with [3H]glu- 
cose in the bath. After the experiment, extracted samples were 
compared with unextracted samples as above. Each sample was 
loaded on an anion-exchange column containing anion-exchange 
resin AG 1-X2 (Bio-Rad). The column was washed five times with water 
to remove free labeled glucose. Alkaline phosphatase (1 U/ml, Sigma) 
was added to the column to cleave off labeled glucose bound to the 
column as [3H]glucose-6-32P. Bound labeled 32p was eluted from the 
column in increasing NaCI concentrations (0 to 500 raM). After correct- 
ing for specific activity of [3H]glucose and [7-32P]ATP, extracted sam- 
ples had an approximate 1:1 ratio of [3H]glucose to 3=p, indicative of 
pure glucose-6-phosphate in the extracted samples. In unextracted 
samples, the ratio of [3H]glucose to ~P was 0.75:1, which agreed with 
the extraction values shown above and suggests that 75% of ~P was 
complexed with glucose as glucose-6-phosphate and 25% was free 
32p or labeled phospholipid in this experimental assay. 
Statistics 
All physiological assays were performed in a paired manner unless 
otherwise noted; thus, a paired Student's t test was used to assess 
statistical significance. A P value of <0.05 was considered significant. 
Data are expressed as mean _+ SEM. In some figures, basal conduc- 
tance was subtracted from the stimulated conductance to graph more 
simply cAMP-activated conductance or ATP-stimulated conductance. 
Materials 
All compounds were obtained from Sigma unless otherwise noted. 
CPT-cAMP was purchased from Boehringer Mannheim (Indianapolis, 
IN), DIDS was Obtained from Sigma, and DPC was obtained from Fluka 
Biochemica (Switzerland). TS-TM-calix[4]arane (TS-TM-Calix4) was a 
gift of Dr. A. Singh and Dr. R. Bridges of the University of Alabama a~t 
Birmingham. CPT-cAMP bath solutions and ATP and other nucleotide 
stocks were made fresh dairy. DIDS, DPC, glybenclamide (glyburide) 
and TS-TM-Calix4 were made up as concentrated stocks and stored 
at 4°C. The sources of all other reagents are identified at the point 
they are discussed in the Experimental Procedures. 
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